Article

SD-OCT provides better structural evaluation of eyes

Ultra high-speed, high-resolution spectral domain optical coherencetomography (SD-OCT) seems to have surpassed the low-resolutionslow-speed OCT and provides video images of structures in eyes withglaucoma that demonstrate the minute details of the glaucomatoustissues.

Ultra high-speed, high-resolution spectral domain optical coherence tomography (SD-OCT) seems to have surpassed the slow-speed, low-resolution OCT and provides video images of structures in eyes with glaucoma that demonstrate the minute details of the glaucomatous tissues.

Teresa Chen, MD, demonstrated the capabilities of the instrument at the annual meeting of the Association for Research in Vision and Ophthalmology. Johannes de Boer, PhD, of Massachusetts General Hospital/Wellman Center for Photomedicine, Harvard Medical School, Boston, developed the SD-OCT.

The prototype system uses a commercially available superluminescent diode with a polarized power of 4.6 mW and a full width at half maximum spectral with of 50 nm centered at 840 nm. The images have a resolution of 6 µm, the optical power directed into the eye was 600 mW, and images can be attained in 1/29 of a second.

"For the first time we have a system that has simultaneous ultra-high resolution and ultra-high acquisition speed and it is more affordable," said Dr. Chen, of the Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston.

Dr. Chen showed selected images of the optic nerve and nerve fiber layer from three patients with varying stages of open-angle glaucoma.

"A benefit of SD-OCT is that we can create videos of the images that are being viewed," Dr. Chen said.

She showed the following pathologies: glaucomatous cupping, bean pot cupping, bayoneting of the blood vessels (double angulations of the vessels), baring of the circumlinear blood vessels, and retinal nerve fiber layer thinning with exposed blood vessels in a case of advanced open-angle glaucoma.

"SD-OCT seems to be a useful technology to visualize these structural changes associated with glaucoma better compared with all commercially available instruments that rely on time domain OCT," Dr. Chen said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.